Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Balding and low testosterone increase risk of urinary stones.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Topical latanoprost acid may help hair growth in women with hair loss.

Dendrobium officinale polysaccharide helps hair regrowth in hair loss mice by affecting local steroid metabolism and hair follicle responses.

A mouse model was created to study hair loss similar to humans.

EH-MSCs may help treat hair loss by reducing inflammation.

Sesamin may help treat hair loss by affecting specific cell pathways.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

AR gene variations don't affect aging markers in men.

DNA phenotyping can predict physical traits like eye, hair, and skin color, improving forensic investigations.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Men with male pattern baldness had higher body fat and obesity-related measurements but similar heart fat and artery thickness compared to healthy men.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.